Sachs Adam David's Form 4/A amendment
AmendedVicarious Surgical Inc. (RBOT) · filed Nov 30, 2022
- Accession no.
- 0001213900-22-076481
- Filed
- Nov 30, 2022
- Trade date
- Nov 28, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Nov 30, 2022
This filing lists 1 derivative transaction. It carries over 3 transactions from the original filing that it did not restate. Open-market sales total $67.6K. It was filed 2 days after the trade.
This amendment restates part of 0001213900-22-076205 (filed Nov 30, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sachs Adam DavidCIK 0001885593 | Director, Officer (President and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 | Class A Common Stock | CConversionDisposed | −11,329 | $0.00 | $0 | 11,239,063 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001213900-22-076205 (filed Nov 30, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 | Class A Common Stock | CConversionAcquired | +11,329 | –F1 | – | 1,254,121 | Direct | |
| Nov 28, 2022 | Class A Common Stock | SSaleDisposed | −11,329 | $3.43F3 | −$38,858.47 | 1,242,792 | Direct | |
| Nov 28, 2022 | Class A Common Stock | SSaleDisposed | −8,325 | $3.45F5 | −$28,721.25 | 1,234,467 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.
Referenced by the price of 1 transaction in Table I.
- F3
This figure is the weighted average sales price of multiple trades ranging from $3.37 to $3.48 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
Referenced by the price of 1 transaction in Table I.
- F5
This figure is the weighted average sales price of multiple trades ranging from $3.36 to $3.62 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.
- F2
On November 30, 2022, the reporting person filed a Form 4 that mistakenly indicated an incorrect transaction date for the conversion of Class B Common Stock. The correct transaction date is 11/28/2022.